<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"
"http://www.w3.org/TR/REC-html40/loose.dtd"> 
<html>
<head>
<title>Untitled Document</title>
<meta http-equiv="Content-Type" content="text/html;charset=utf-8">
</head>
<body>
<p>

# en/1.xml.gz<br>
# sl/1.xml.gz

<p><hr>
(src)="1"> This summary was last updated in September 2017 . <br>
(trg)="1"> Povzetek je bil nazadnje posodobljen septembra 2017 . <br>
<hr>
(src)="2"> EPAR summary for the public <br>
(trg)="2"> Povzetek EPAR za javnost <br>
<hr>
(src)="3"> The injection is given under the skin in the neck just behind the ear . <br>
(trg)="3"> Injekcija se vbrizga pod kožo v vrat neposredno za ušesom . <br>
<hr>
(src)="4"> The European Commission granted a marketing authorisation valid throughout the EU for Improvac on 11 May 2009 . <br>
(trg)="4"> Evropska komisija je dovoljenje za promet z zdravilom Improvac , veljavno po vsej Evropski uniji , izdala 11 . maja 2009 . <br>
<hr>
(src)="5"> The full EPAR for Improvac can be found on the Agency 's website : ema.europa.eu / Find medicine / Veterinary medicines / European public assessment reports . <br>
(trg)="5"> Celotno evropsko javno poročilo o oceni zdravila Improvac je na voljo na spletni strani agencije : ema.europa.eu / Find medicine / Veterinary medicines / European public assessment reports . <br>
<hr>
(src)="6"> In case of skin or eye contact the affected area should be rinsed immediately with water . <br>
(trg)="6"> V primeru stika s kožo ali očmi je treba prizadeto področje nemudoma izprati z vodo . <br>
<hr>
(src)="7"> These may include a temporary reduction in sex hormone levels and reduced ability to reproduce in men and in women , including problems with pregnancy . <br>
(trg)="7"> To lahko vključujejo začasno zmanjšanje ravni spolnih hormonov in zmanjšano zmožnost razmnoževanja pri moških in ženskah , vključno s težavami z nosečnostjo . <br>
<hr>
(src)="8"> It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union ( EU ) and its conditions of use . <br>
(trg)="8"> Pojasnjuje , kako je agencija ocenila to zdravilo za uporabo v veterinarski medicini , na podlagi česar je priporočila njegovo odobritev v Evropski uniji ( EU ) in pogoje njegove uporabe . <br>
<hr>
(src)="9"> This is a summary of the European public assessment report ( EPAR ) for Improvac . <br>
(trg)="9"> To je povzetek evropskega javnega poročila o oceni zdravila ( EPAR ) za zdravilo Improvac . <br>
<hr>
(src)="10"> The Agency 's Committee for Medicinal Products for Veterinary Use ( CVMP ) concluded that Improvac 's benefits are greater than its risks and recommended that it be approved for use in the EU . <br>
(trg)="10"> Odbor za zdravila za uporabo v veterinarski medicini ( CVMP ) pri agenciji je zaključil , da so koristi zdravila Improvac večje od z njim povezanih tveganj , in priporočil , da se odobri za uporabo v EU . <br>
<hr>
(src)="11"> The first injection had a limited effect , but the second injection is followed by production of antibodies against GnRF . <br>
(trg)="11"> Prva injekcija je imela omejen učinek , drugi injekciji pa je sledilo nastajanje protiteles proti GnRF . <br>
<hr>
(src)="12"> What is Improvac and what is it used for ? <br>
(trg)="12"> Kaj je zdravilo Improvac in za kaj se uporablja ? <br>
<hr>
(src)="13"> The most common side effects with Improvac ( which may affect more than 1 in 10 pigs ) are injection site swelling , which gradually resolves but in 20 to 30 % of animals will last for more than 6 weeks , and a short-lived increase in body temperature of around 0.5 ˚ C within 24 hours of vaccination . <br>
(trg)="13"> Najpogostejša neželena učinka zdravila Improvac ( ki lahko prizadeneta več kot 1 prašiča od 10 ) sta oteklina na mestu injiciranja , ki sicer postopno izzveni , a pri 20 do 30 % živalih vseeno traja več kot šest tednov , in kratkotrajno povišanje telesne temperature za približno 0,5 ˚ C v 24 urah po cepljenju . <br>
<hr>
(src)="14"> It is not intended to provide practical advice on how to use Improvac . <br>
(trg)="14"> Povzetek ni namenjen zagotavljanju praktičnih nasvetov o njegovi uporabi . <br>
<hr>
(src)="15"> The risk of these effects occurring is greater after a second or subsequent accidental injection than after a first injection . <br>
(trg)="15"> Tveganje za pojav teh učinkov je večje po drugem ali poznejšem nenamernem injiciranju kot po prvem injiciranju . <br>
<hr>
(src)="16"> What are the precautions for the person who gives the medicine or comes into contact with the animal ? <br>
(trg)="16"> Kakšne previdnostne ukrepe mora upoštevati oseba , ki daje zdravilo ali pride v stik z živaljo ? <br>
<hr>
(src)="17"> Improvac must not be given to pigs by women who are or who may be pregnant . <br>
(trg)="17"> Zdravila Improvac prašičem ne smejo dajati ženske , ki so ali bi lahko bile noseče . <br>
<hr>
(src)="18"> Three field studies investigated the effectiveness of Improvac in reducing aggression and sexual behaviour in pigs . <br>
(trg)="18"> V treh terenskih študijah so proučevali učinkovitost zdravila Improvac pri zmanjševanju agresivnosti in spolnega vedenja pri prašičih . <br>
<hr>
(src)="19"> Improvac also reduces aggressive and sexual ( mounting ) behaviour in pigs . <br>
(trg)="19"> Prav tako zmanjša agresivno in spolno vedenje ( zaskakovanje ) pri prašičih . <br>
<hr>
(src)="20"> What is the withdrawal period in food-producing animals ? <br>
(trg)="20"> Kako dolgo traja karenca pri živalih , namenjenih za proizvodnjo hrane ? <br>
<hr>
(src)="21"> Why is Improvac approved ? <br>
(trg)="21"> Zakaj je bilo zdravilo Improvac odobreno ? <br>
<hr>
(src)="22"> Improvac starts to be effective within 1 week after the second injection . <br>
(trg)="22"> Zdravilo Improvac začne učinkovati v enem tednu po drugi injekciji . <br>
<hr>
(src)="23"> Boar taint is caused by the production and build-up of the natural compounds androstenone and skatole in the flesh of these animals . <br>
(trg)="23"> Vonj po merjascu je posledica nastajanja in kopičenja naravnih spojin androstenona in skatola v mesu teh živali . <br>
<hr>
(src)="24"> The first injection is from 8 weeks of age and the second 4 to 6 weeks before slaughter . <br>
(trg)="24"> Prva injekcija se daje pri starosti od osem tednov dalje , druga pa od štiri do šest tednov pred zakolom . <br>
<hr>
(src)="25"> Accidental self-injection of Improvac may produce similar effects in people to those seen in pigs . <br>
(trg)="25"> Nenamerno samoinjiciranje zdravila Improvac lahko pri ljudeh povzroči podobne učinke kot pri prašičih . <br>
<hr>
(src)="26"> The withdrawal period for meat from pigs treated with Improvac is ‘ zero ' days , which means there is no mandatory waiting time . <br>
(trg)="26"> Karenca za meso prašičev , zdravljenih z zdravilom Improvac , je nič dni , kar pomeni , da ni obvezne čakalne dobe . <br>
<hr>
(src)="27"> Improvac must only be used with a safety device including a needle guard and a mechanism to prevent accidental operation of the trigger . <br>
(trg)="27"> Zdravilo Improvac se lahko uporablja samo z varnostnim pripomočkom , ki vključuje varovalo za iglo in mehanizem za preprečevanje naključnega delovanja sprožilca . <br>
<hr>
(src)="28"> Boar taint is the offensive odour or taste which may be present in pork or pork products from non-castrated mature male pigs . <br>
(trg)="28"> Vonj po merjascu je neprijeten vonj ali okus , ki je lahko prisoten v svinjini ali izdelkih iz prašičjega mesa nekastriranih dozorelih prašičih . <br>
<hr>
(src)="29"> What benefits of Improvac have been shown in studies ? <br>
(trg)="29"> Kakšne koristi je zdravilo Improvac izkazalo v študijah ? <br>
<hr>
(src)="30"> This temporarily inhibits release of steroids from the testicles , including androstenone , one of the two causes of boar taint . <br>
(trg)="30"> S tem se začasno zavre sproščanje steroidov iz mod , vključno z androstenonom , ki je eden od dveh povzročiteljev vonja po merjascu . <br>
<hr>
(src)="31"> What are the risks associated with Improvac ? <br>
(trg)="31"> Kakšna tveganja so povezana z zdravilom Improvac ? <br>
<hr>
(src)="32"> Skatole , the other major cause of boar taint , is produced in the intestines and levels are reduced since the reduced level of sex hormones allows the liver to metabolise ( break it down ) more efficiently . <br>
(trg)="32"> Skatol , drugi glavni povzročitelj vonja po merjascu , nastaja v črevesju , njegova količina pa se zmanjša zaradi znižanih ravni spolnih hormonov , kar omogoča , da ga jetra učinkoviteje presnavljajo ( razgrajujejo ) . <br>
<hr>
(src)="33"> Improvac is used as an alternative to physical castration ( removal of the testes ) to reduce the presence of these compounds . <br>
(trg)="33"> Zdravilo Improvac se uporablja kot alternativa fizični kastraciji ( odstranitvi mod ) za zmanjšanje prisotnosti teh spojin . <br>
<hr>
(src)="34"> The levels of antibodies decline with time but are still high enough to be reliably effective 4 to 6 weeks after the second injection . <br>
(trg)="34"> Količina protiteles sčasoma upada , vendar jih je še vedno dovolj , da so zanesljivo učinkovita od štiri do šest tednov po drugi injekciji . <br>
<hr>
(src)="35"> For the full list of restrictions and all side effects reported with Improvac , see the package leaflet . <br>
(trg)="35"> Za celoten seznam omejitev in neželenih učinkov , o katerih so poročali pri uporabi zdravila Improvac , glejte navodilo za uporabo . <br>
<hr>
(src)="36"> Two studies showed reduction of aggression and mounting from 1 to 2 weeks after the second injection of Improvac , while the third studied the long term effect on aggression and mounting after 4 weeks only . <br>
(trg)="36"> V dveh študijah so dokazali zmanjšanje agresivnosti in zaskakovanja v enem do dveh tednih po drugi injekciji zdravila Improvac , v tretji študiji pa so proučevali samo dolgoročni učinek na agresivnost in zaskakovanje po štirih tednih . <br>
<hr>
(src)="37"> In addition Improvac treated pigs had reduced blood levels of testosterone . <br>
(trg)="37"> Poleg tega so imeli prašiči , zdravljeni z zdravilom Improvac , nižje ravni testosterona v krvi . <br>
<hr>
(src)="38"> For further information , see the package leaflet . <br>
(trg)="38"> Za več informacij glejte navodilo za uporabo . <br>
<hr>
(src)="39"> Improvac works by stimulating the pig 's immune system to produce antibodies against gonadotropin-releasing hormone ( GnRH ) , part of the system that controls sexual development . <br>
(trg)="39"> Zdravilo Improvac spodbudi imunski sistem prašiča k tvorbi protiteles proti gonadotropin sproščajočemu hormonu ( GnRH ) , ki je del sistema , ki nadzoruje spolni razvoj . <br>
<hr>
(src)="40"> Androstenone and skatole levels are reduced from 4 to 6 weeks after the second injection and reduction of aggression and sexual behaviour is seen from 1 to 2 weeks after the second injection . <br>
(trg)="40"> Ravni androstenona in skatola se znižajo v štirih do šestih tednih po drugi injekciji , agresivnost in spolno vedenje pa v enem do dveh tednih po drugi injekciji . <br>
<hr>
(src)="41"> The withdrawal period is the time required after administration of a medicine before an animal can be slaughtered and the meat used for human consumption . <br>
(trg)="41"> Karenca je čas , ki mora preteči po uporabi zdravila , preden se lahko žival zakolje in meso uporabi za prehrano ljudi . <br>
<hr>
(src)="42"> Improvac is given to male pigs as two injections with at least a 4 week interval . <br>
(trg)="42"> Zdravilo se prašičem daje v obliki dveh injekcij z vsaj štiritedenskim razmakom . <br>
<hr>
(src)="43"> Other information about Improvac ? <br>
(trg)="43"> Druge informacije o zdravilu Improvac <br>
<hr>
(src)="44"> In case of accidental self-injection , medical advice should be sought immediately and the package leaflet or label shown to the doctor . <br>
(trg)="44"> V primeru nenamernega samoinjiciranja nemudoma poiščite zdravniško pomoč in zdravniku pokažite navodilo za uporabo ali nalepko . <br>
<hr>
(src)="45"> In a number of field studies pigs treated with Improvac were comparable to surgically castrated pigs in terms of levels of androstenone and skatole at slaughter . <br>
(trg)="45"> V več terenskih študijah so imeli prašiči , zdravljeni z zdravilom Improvac , ob zakolu primerljive ravni androstenona in skatola kot kirurško kastrirani prašiči . <br>
<hr>
(src)="46"> Special care should be taken to avoid accidental self-injection . <br>
(trg)="46"> Da bi se izognili samoinjiciranju , je potrebna še posebna previdnost . <br>
<hr>
(src)="47"> Improvac is a veterinary medicine used in male pigs to reduce ‘ boar taint ' in the meat obtained from them after slaughter . <br>
(trg)="47"> Improvac je zdravilo za uporabo v veterinarski medicini , ki se uporablja pri prašičjih samcih za zmanjševanje vonja po merjascu v mesu , ki ga od njih pridobijo po zakolu . <br>
<hr>
(src)="48"> Improvac is available as a solution for injection and can only be obtained with a prescription . <br>
(trg)="48"> Zdravilo Improvac je na voljo v obliki raztopine za injiciranje , njegovo predpisovanje in izdaja pa je le na recept . <br>
<hr>
(src)="49"> Improvac must not be given to female pigs or to male pigs intended for breeding . <br>
(trg)="49"> Zdravilo Improvac se ne sme dajati svinjam ali prašičem , namenjenim za vzrejo . <br>
<hr>
(src)="50"> The active substance in Improvac is an analogue of ( similar to ) gonatadotropin releasing factor ( GnRF ) linked to a carrier protein obtained from the bacterium Corynebacterium diphtheriae . <br>
(trg)="50"> Zdravilna učinkovina v zdravilu Improvac je analog ( tj. podobna snov ) gonadotropin sproščajočega faktorja ( GnRF ) , vezan na nosilno beljakovino , pridobljeno iz bakterije Corynebacterium diphtheriae . <br>
<hr>
(src)="51"> Safety information has been included in the summary of product characteristics and the package leaflet for Improvac , including the appropriate precautions to be followed by healthcare professionals and animal owners or keepers . <br>
(trg)="51"> V povzetek glavnih značilnosti zdravila in navodilo za njegovo uporabo so bile vključene informacije o varnosti , vključno s previdnostnimi ukrepi , ki jih morajo upoštevati zdravstveni delavci in lastniki ali skrbniki živali . <br>
<hr>
(src)="52"> Improvac gonadotropin releasing factor ( GnRF ) analogue-protein conjugate <br>
(trg)="52"> Improvac analog gonadotropin sproščajočega faktorja ( GnRF ) - konjugiran protein <br>
<hr>
(src)="53"> For practical information about using Improvac , animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist . <br>
(trg)="53"> Za praktične informacije o uporabi zdravila Improvac naj lastniki ali skrbniki živali preberejo navodilo za uporabo ali se posvetujejo z veterinarjem ali farmacevtom . <br>
<hr>
(src)="54"> For more information about treatment with Improvac , animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist . <br>
(trg)="54"> Za več informacij o zdravljenju z zdravilom Improvac naj lastniki ali skrbniki živali preberejo navodilo za uporabo ali se posvetujejo z veterinarjem ali farmacevtom . <br>
<hr>
(src)="55"> How is Improvac used ? <br>
(trg)="55"> Kako se zdravilo Improvac uporablja ? <br>
<hr>
(src)="56"> Improvac also contains a compound derived from the sugar dextran as an adjuvant ( ingredient that strengthens the immune response ) . <br>
(trg)="56"> Zdravilo Improvac kot dodatek ( sestavino , ki okrepi imunski odziv ) vsebuje tudi spojino , pridobljeno iz sladkorja dekstrana . <br>
<hr>
(src)="57"> Improvac contains the active substance gonadotropin releasing factor ( GnRF ) analogue-protein conjugate . <br>
(trg)="57"> Zdravilo Improvac vsebuje zdravilno učinkovino analog gonadotropin sproščajočega faktorja ( GnRF ) konjugiran protein . <br>
<hr>
(src)="58"> How does Improvac work ? <br>
(trg)="58"> Kako zdravilo Improvac deluje ? <br>
<hr>
(src)="59"> This summary was last updated in 05-2012 . <br>
(trg)="59"> Povzetek je bil nazadnje posodobljen 05-2012 . <br>
<hr>
(src)="60"> It must also not be used in patients : <br>
(trg)="60"> Prav tako se ne sme uporabljati pri bolnikih : <br>
<hr>
(src)="61"> The European Commission granted a marketing authorisation valid throughout the European Union for Preotact on 24 April 2006 . <br>
(trg)="61"> Evropska komisija je dovoljenje za promet z zdravilom Preotact , veljavno po vsej Evropski uniji , odobrila dne 24 . aprila 2006 . <br>
<hr>
(src)="62"> The main measure of effectiveness was the rate of vertebral fractures after 18 months of treatment . <br>
(trg)="62"> Glavno merilo učinkovitosti je bilo število vretenčnih zlomov po 18 mesecih zdravljenja . <br>
<hr>
(src)="63"> The full EPAR for Preotact can be found on the Agency 's website : ema.europa.eu / Find medicine / Human medicines / European Public Assessment Reports . <br>
(trg)="63"> Celotno evropsko javno poročilo o oceni zdravila ( EPAR ) za zdravilo Preotact je na voljo na spletni strani agencije : ema.europa.eu / Find medicine / Human medicines / European Public Assessment Reports . <br>
<hr>
(src)="64"> It also increases the absorption of calcium from food and prevents too much calcium from being lost in the urine . <br>
(trg)="64"> Poleg tega poveča absorpcijo kalcija iz hrane in preprečuje izgubo velike količine kalcija v urinu . <br>
<hr>
(src)="65"> Preotact has been studied in one main study involving 2,532 women with postmenopausal osteoporosis . <br>
(trg)="65"> Zdravilo Preotact so raziskovali v eni glavni študiji , ki je vključevala 2 532 žensk s postmenopavzalno osteoporozo . <br>
<hr>
(src)="66"> • who have bone cancer or cancer that has spread to the bones , <br>
(trg)="66"> • ki imajo kostnega raka ali raka , ki se je razširil na kosti ; <br>
<hr>
(src)="67"> About two-thirds of the women continued taking Preotact for up to two years , and their bone density was measured . <br>
(trg)="67"> Okoli dve tretjini žensk je zdravilo Preotact jemalo še dve leti , pri čemer so merili njihovo kostno gostoto . <br>
<hr>
(src)="68"> This is a summary of the European public assessment report ( EPAR ) for Preotact . <br>
(trg)="68"> To je povzetek evropskega javnega poročila o oceni zdravila ( EPAR ) za zdravilo Preotact . <br>
<hr>
(src)="69"> Other information about Preotact <br>
(trg)="69"> Druge informacije o zdravilu Preotact <br>
<hr>
(src)="70"> What benefit has Preotact shown during the studies ? <br>
(trg)="70"> Kakšne koristi je zdravilo Preotact izkazalo med študijami ? <br>
<hr>
(src)="71"> For more information about treatment with Preotact , read the package leaflet ( also part of the EPAR ) or contact your doctor or pharmacist . <br>
(trg)="71"> Za več informacij o zdravljenju z zdravilom Preotact preberite navodilo za uporabo ( ki je prav tako del EPAR ) ali se posvetujte z zdravnikom ali farmacevtom . <br>
<hr>
(src)="72"> What is the risk associated with Preotact ? <br>
(trg)="72"> Kakšna tveganja so povezana z zdravilom Preotact ? <br>
<hr>
(src)="73"> • who have a bone disease that is not osteoporosis , <br>
(trg)="73"> • ki imajo kakršno koli drugo kostno bolezen , ki ni osteoporoza ; <br>
<hr>
(src)="74"> • who have any disorder that affects the calcium and phosphate balance in the body , <br>
(trg)="74"> • ki imajo kakršno koli obolenje , ki vpliva na uravnavanje ravni kalcija in fosfatov v telesu ; <br>
<hr>
(src)="75"> The medicine can only be obtained with a prescription . <br>
(trg)="75"> Izdaja zdravila je le na recept . <br>
<hr>
(src)="76"> The recommended dose of Preotact is 100 micrograms , given once a day as an injection under the skin into the abdomen . <br>
(trg)="76"> Priporočeni odmerek zdravila Preotact je 100 mikrogramov , ki se enkrat na dan injicira pod kožo v predel trebuha . <br>
<hr>
(src)="77"> The CHMP decided that Preotact 's benefits are greater than its risks and recommended that it be given marketing authorisation . <br>
(trg)="77"> CHMP je zaključil , da so koristi zdravila Preotact večje od z njim povezanih tveganj , in priporočil , da se zanj odobri dovoljenje za promet . <br>
<hr>
(src)="78"> The most common side effects with Preotact ( seen in more than 1 patient in 10 ) are hypercalcaemia ( high blood calcium levels ) , hypercalciuria ( high calcium levels in the urine ) and nausea ( feeling sick ) . <br>
(trg)="78"> Najpogostejši neželeni učinki zdravila Preotact ( opaženi pri več kot 1 od 10 bolnikov ) so hiperkalciemija ( visoka raven kalcija v krvi ) , hiperkalciurija ( visoka raven kalcija v urinu ) in navzeja ( slabost ) . <br>
<hr>
(src)="79"> The risk reduction was higher in women who already had a fractured vertebra in the past , and in women whose score for spine bone density was already low at the start of the study , indicating that they had a more fragile spine . <br>
(trg)="79"> Najbolj se je tveganje zmanjšalo pri ženskah , ki so v preteklosti že imele zlomljena vretenca , in pri ženskah , ki so imele že na začetku pri merjenju nizko kostno gostoto hrbtenice , kar kaže na to , da so imele krhkejšo hrbtenico . <br>
<hr>
(src)="80"> It is produced by a method known as ‘ recombinant DNA technology ' : the hormone is made by a bacterium that has received a gene ( DNA ) that makes it able to produce it . <br>
(trg)="80"> Proizvaja se z metodo , znano kot „ tehnologija rekombinantne DNK “ , pri kateri bakterija prejme gen ( DNK ) , s katerim lahko tvori hormon . <br>
<hr>
(src)="81"> It explains how the Committee for Medicinal Products for Human Use ( CHMP ) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Preotact . <br>
(trg)="81"> Pojasnjuje , kako je Odbor za zdravila za uporabo v humani medicini ( CHMP ) ocenil zdravilo Preotact , na podlagi česar je oblikoval mnenje za odobritev dovoljenja za promet z njim in priporočila glede pogojev njegove uporabe . <br>
<hr>
(src)="82"> Gradually , the bones become thin and fragile , and more likely to break ( fracture ) . <br>
(trg)="82"> Kosti se tako postopoma redčijo in postajajo krhkejše ter posledično bolj lomljive ( podvržene zlomu ) . <br>
<hr>
(src)="83"> Preotact significantly reduced the risk of having a vertebral fracture , in comparison with placebo : after 18 months , there were 42 vertebral fractures in the placebo group ( 3.37 ) and 17 in the Preotact group ( 1.32 ) . <br>
(trg)="83"> Zdravilo Preotact je v primerjavi s placebom znatno zmanjšalo tveganje za vretenčni zlom : po 18 mesecih je bilo v skupini , ki je prejemala placebo , zabeleženih 42 vretenčnih zlomov ( 3,37 % ) , medtem ko je bilo v skupini , ki je prejemala zdravilo Preotact , zabeleženih 17 zlomov ( 1,32 % ) . <br>
<hr>
(src)="84"> Osteoporosis is more common in women after the menopause , when the levels of the female hormone oestrogen fall . <br>
(trg)="84"> Osteoporoza je pogostejša pri ženskah v obdobju po menopavzi , ko upade količina ženskega hormona estrogena . <br>
<hr>
(src)="85"> Preotact must not be used in people who are hypersensitive ( allergic ) to parathyroid hormone or any of the other ingredients . <br>
(trg)="85"> Zdravila Preotact ne smejo uporabljati osebe , ki so preobčutljive za ( alergične na ) paratiroidni hormon ali katero koli drugo sestavino zdravila . <br>
<hr>
(src)="86"> Why has Preotact been approved ? <br>
(trg)="86"> Zakaj je bilo zdravilo Preotact odobreno ? <br>
<hr>
(src)="87"> The bone density was also the main measure in another study , which looked at the use of Preotact with or without alendronate ( a bisphosphonate ) . <br>
(trg)="87"> Kostna gostota je bila prav tako glavno merilo v drugi študiji , v kateri so proučevali uporabo zdravila Preotact v kombinaciji z alendronatom ( difosfonatom ) ali brez njega . <br>
<hr>
(src)="88"> Preotact parathyroid hormone <br>
(trg)="88"> Preotact paratiroidni hormon <br>
<hr>
(src)="89"> Patients may inject themselves once they have been trained ( a user manual is supplied ) . <br>
(trg)="89"> Bolnice si lahko zdravilo injicirajo same , potem ko so bile za to ustrezno usposobljene ( navodila za uporabo so priložena ) . <br>
<hr>
(src)="90"> When the cartridge is inserted in the special injection pen and the pen screwed together , or when the pre-filled pen is prepared for use , the powder and solvent mix to make up the solution for injection . <br>
(trg)="90"> Ko se vložek vstavi v posebni injekcijski peresnik in se ta tesno privije ali ko se napolnjeni injekcijski peresnik pripravi za uporabo , se prašek in vehikel zmešata v raztopino za injiciranje . <br>
<hr>
(src)="91"> The study of Preotact with alendronate showed that using alendronate after Preotact can bring further increases in bone density . <br>
(trg)="91"> Študija uporabe zdravila Preotact v kombinaciji z alendronatom je pokazala , da lahko uporaba alendronata po jemanju zdravila Preotact še dodatno poveča kostno gostoto . <br>
<hr>
(src)="92"> Osteoporosis happens when not enough new bone grows to replace the bone that is naturally broken down . <br>
(trg)="92"> Do osteoporoze pride , ko tvorjenje nove kostne mase ni več zadostno , da bi nadomestilo naravno razgradnjo kosti . <br>
<hr>
(src)="93"> Preotact was compared with placebo ( a dummy treatment ) . <br>
(trg)="93"> Zdravilo Preotact so primerjali s placebom ( zdravilom brez zdravilne učinkovine ) . <br>
<hr>
(src)="94"> Increases in bone density were also seen during the study . <br>
(trg)="94"> V študiji so zabeležili tudi povečanje kostne gostote . <br>
<hr>
(src)="95"> Preotact has been shown to significantly reduce vertebral ( spine ) fractures , but not hip fractures . <br>
(trg)="95"> Dokazano je bilo , da zdravilo Preotact znatno zmanjšuje tveganje za vretenčne zlome ( zlome hrbtenice ) , ne pa tudi tveganja za zlom kolka . <br>
<hr>
(src)="96"> What is Preotact ? <br>
(trg)="96"> Kaj je zdravilo Preotact ? <br>
<hr>
(src)="97"> For the full list of all side effects with Preotact , see the package leaflet . <br>
(trg)="97"> Za celoten seznam neželenih učinkov , o katerih so poročali pri uporabi zdravila Preotact , glejte navodilo za uporabo . <br>
<hr>
(src)="98"> The parathyroid hormone in Preotact is identical to the human parathyroid hormone . <br>
(trg)="98"> Paratiroidni hormon v zdravilu Preotact je povsem enak človeškemu paratiroidnemu hormonu . <br>
<hr>
(src)="99"> Preotact is used for the treatment of osteoporosis ( a disease that makes bones fragile ) in postmenopausal women who are at high risk of fractures . <br>
(trg)="99"> Zdravilo Preotact se uporablja za zdravljenje osteoporoze ( bolezni , ki povzroča krhkost kosti ) pri ženskah v obdobju po menopavzi , pri katerih obstaja povečano tveganje za zlom kosti . <br>
<hr>
(src)="100"> Preotact contains parathyroid hormone , which stimulates bone formation by acting on osteoblasts ( bone forming cells ) . <br>
(trg)="100"> Zdravilo Preotact vsebuje paratiroidni hormon , ki stimulira tvorbo kosti tako , da deluje na osteoblaste ( celice , ki tvorijo kostno maso ) . <br>
<hr>
</body>
</html>
